Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,824.66
(
0.62%
)
US TECH 100
24,376.00
(
0.55%
)
Dow Jones
48,185.80
(
0.58%
)
Brent Oil
94.21
(
-0.25%
)
Bitcoin
72,004.08
(
0.30%
)
News Focus
News Focus
Post# of 257375
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

NP1986

Send PM Follow Ignore
Followers 6
Posts 541
Boards Moderated 0
Alias Born 06/07/2011

NP1986

Re: Fuma102 post# 126229

Tuesday, 09/06/2011 10:04:29 PM

Tuesday, September 06, 2011 10:04:29 PM

Post# of 257375
Thanks for posting the comparison. Even though it is not a JAK inhibitor, RIGL/AZN's fostamitinib is also worth keeping an eye on.

I think there will be a lot of patient-driven interest in oral drugs for RA.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today